Alpha Profiles · Company Profile

GENMAB A/S

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/genmab-a-s

Entity: Public listing published
Primary listing: NASDAQ: GMAB
Verification: Partially verified
Last reviewed: 2026-10-18T04:47:56.958128+00:00

Overview

Alpha's canonical identity and public leadership record for GENMAB A/S.

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

9 public records

Anthony Pagano

Executive Vice President & Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 86%
Evidence: Genmab A/S key executivesMay 4, 2026

Christopher Cozic

Executive Vice President & Chief People Officer

State: confirmed
Effective: Date not stated
Confidence: 86%
Evidence: Genmab A/S key executivesMay 4, 2026

Gregory David Emil Mueller

Executive VP, General Counsel & Chief Legal Officer

State: confirmed
Effective: Date not stated
Confidence: 86%
Evidence: Genmab A/S key executivesMay 4, 2026

Jan van de Winkel

Co-Founder, President & Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 86%
Evidence: Genmab A/S key executivesMay 4, 2026

Judith V. Klimovsky

Executive Vice President & Chief Development Officer

State: confirmed
Effective: Date not stated
Confidence: 86%
Evidence: Genmab A/S key executivesMay 4, 2026

Martine J. van Vugt

Executive Vice President & Chief Strategy Officer

State: confirmed
Effective: Date not stated
Confidence: 86%
Evidence: Genmab A/S key executivesMay 4, 2026

Mijke Zachariasse

Vice President, Head of Antibody Research Materials & Director

State: confirmed
Effective: Date not stated
Confidence: 86%
Evidence: Genmab A/S key executivesMay 4, 2026

Rayne Waller

Executive Vice President & Chief Technical Operations Officer

State: confirmed
Effective: Date not stated
Confidence: 86%
Evidence: Genmab A/S key executivesMay 4, 2026

Tahamtan Ahmadi

Executive Vice President, Chief Medical Officer & Head of Experimental Medicines

State: confirmed
Effective: Date not stated
Confidence: 86%
Evidence: Genmab A/S key executivesMay 4, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Oct 18, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.

Board roles

0 public records

Board roster coverage is NOT_ASSERTED. An empty list is not evidence that this company has no board.

Source record

Alpha canonical company public projection

Supports Company identity, Published leadership, Entity status boundary

Reviewed 2026-10-18T04:47:56.958128+00:00